Botulinum injections for the treatment of bladder symptoms of multiple sclerosis

Abstract

Minimally invasive injections of botulinum neurotoxin type A have been shown to be exceptionally effective in producing a prolonged improvement in urinary continence in patients with multiple sclerosis. This treatment is likely to have a major impact on future management.